Lack Of VC Industry In Asia Means Public Institutions Need To Step In and Take On Risk
This article was originally published in PharmAsia News
Executive Summary
SINGAPORE - Public institutions will need to step in and narrow the sizable gap between early research and commercialization in much of Asia, experts told an April 16 panel at the BioMedical Asia conference in Singapore